BridgeBio Oncology Therapeutics Inc — Quarterly Balance Sheet (NASDAQ:BBOT)

Financials

Total revenue 3 0003 1822 4451 1593.44 M 3.45 M Gross profit 3 0003 1822 4451 1593.44 M 3.45 M Operating expenses 146.85 K-1.41 M7.96 M1.14 M49.18 M 56.87 M Selling/general/admin expenses 146.85 K-1.41 M2.42 M1.12 M14.13 M 16.26 M Research & development ————35.05 M — Operating income -146.85 K-20.03 M-2.42 M-1.12 M49.18 M 25.61 M Non-Operating Income, Total 2.48 M2.31 M1.93 M2.04 M4.42 M 10.71 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 2.48 M2.31 M1.93 M2.04 M4.39 M 10.68 M Unusual income/expense ————30 K — Pretax income 2.33 M-17.72 M-487.39 K918.31 K53.6 M 36.32 M Equity in earnings ————— — Taxes ——000 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 2.33 M-46.99 M-487.39 K-21.62 M44.76 M -24.34 M Discontinued operations ————— — Net income 2.33 M-46.99 M-487.39 K-21.62 M44.76 M -24.34 M Dilution adjustment 2.55 M51.19 M2.96 M24.62 M— — Preferred dividends 2.55 M2.25 M1.99 M2.07 M— — Diluted net income available to common stockholders 2.33 M1.95 M487.39 K918.31 K44.76 M 48.12 M Basic earnings per share (Basic EPS) 0.20.180.040.08-1.03 -0.73 Diluted earnings per share (Diluted EPS) 0.20.180.040.08-1.03 -0.73 Average basic shares outstanding 23.51 M21.16 M23.51 M23.51 M43.49 M 111.67 M Diluted shares outstanding 23.51 M21.24 M23.51 M23.51 M43.49 M 111.74 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —